Breast Health

COVID-19

Cervical Health 

Contraception

Curbside Consults

Dermatology

Drug Pipeline News

Endometriosis

Genetic Testing

Gynecologic Oncology

Gynecology

Fetal Imaging

Abnormal Obstetrical Ultrasound

Ultrasound

Women's Imaging

Breast Imaging

Women's Ultrasound

Imaging

Infertility

LARC

Legally Speaking

Life Transitions

Malpractice

Menopause

Mental Health

Noninvasive Prenatal Testing

Obstetrics

Opinion

Osteoporosis

Pediatrics

Practice Management

Pregnancy and Birth

Sexual Health

Sexually Transmitted Infections

Surgery

Technology

Urology

Uterine Fibroids

Vulvovaginal Disease

Well Woman

About

News

Media

Podcasts

Insights

Medical World News

Peer Exchange

Peers & Perspectives

Videos

Conferences

Conference Coverage

Conference Listing

Publications

Contemporary OB/GYN® Journal

Digital Supplements

CME/CE

Resources

Physician Fact Sheets

Interactive Tools

Supplements and Featured Publications

Subscribe

Editorial Board

Partnerships

Articles

A new study found that states with restrictive abortion laws have seen an increase in babies born with cyanotic congenital heart disease, highlighting potential long-term health care challenges.

Restrictive abortion laws linked to offspring heart disease

A recent study reveals significantly elevated placental interleukin 6 and vascular endothelial growth factor receptor 2 messenger RNA expression in fetal death cases, highlighting inflammation and impaired fetal protection mechanisms.

Expression of mRNA linked to fetal death risk

A recent study identified distinct gene signatures in placentae from gestational diabetes and pregestational diabetes pregnancies, offering potential for improved diagnosis and treatment strategies.

Unique gene signatures reported across diabetes subtypes

A study found that a first trimester circulating microparticle biomarker can help predict spontaneous preterm birth risk, potentially improving early intervention and neonatal outcomes.

New biomarker offers early detection of preterm birth risk

Advertise

Contact Us

Job Board

Terms of Use

Privacy Policy

Do Not Sell My Personal Information

Contemporary OB/GYN

Facebook

LinkedIn

RSS Feed

Spotlight

A Psychedelic to Treat Postpartum Depression?

CMV: In the Know

RSV Roundtable

STIs

Supplement: Closing the Gap in Cervical Cancer Screening

Vaginismus: Managing a Misunderstood and Underdiagnosed Condition

Why vNOTES Make Sense for My Patients

1rem

Authors

The second slideshow of our gynecologic ultrasound collection reviews more commonly missed diagnoses and offers tips for recognizing them on ultrasound.

Ultrasound images: Gynecologic diagnoses (Part 2)

A 27-year-old woman presents with an 18-month history of vulvar irritation. She is otherwise healthy except for episodes of depression. She has tried multiple agents for her condition including topical steroids, Vagisil, antibiotics, and fluconazole. She used oral steroids but developed knee pain. Tacrolimus has not helped. A biopsy revealed lichen simplex chronicus. Immunofluorescent studies were negative.

A 27-year-old woman presents with an 18-month history of vulvar irritation. She has tried multiple agents for her condition including topical steroids, Vagisil, antibiotics, and fluconazole without relief. What's your diagnosis?

Vulvar irritation in a 27-year-old woman

Saying "obstetrician-gynecologist" is a mouthful for most people, and it's probably the most abbreviated specialty in medicine, both spoken and written. However, there doesn't seem to be a consensus on how to pronounce OB-GYN. First, is it the two-syllable "O-B" or the monosyllabic "Ob"? Second, is it "gin" or "gyne" (like "Lyme")? I wonder if you have a preference. I know I do.

Almost nobody says "obstetrician-gynecologist" when speaking about these specialist physicians. But what's the "correct" way to pronounce OB/GYN?

Is It Ob-Gin or Ob-Gyne?

Stress urinary incontinence

Wanda Filer, MD, MBA FAAFP, from Pelvital, discussed barriers to stress urinary incontinence (SUI) treatment, and how OB-GYNs may address these issues.

SUI is a widespread condition affecting many women, with urinary incontinence in general impacting approximately 62% of US women. Among these cases, stress urinary incontinence is the most common. 

Despite its prevalence, many women feel embarrassed or reluctant to discuss their symptoms with a health care provider. There is a cultural normalization of the condition, as women are frequently exposed to advertisements for incontinence pads, leading them to believe they should manage the issue rather than seek treatment. As a result, most women do not bring up their symptoms to a clinician for at least 10 years, prolonging their discomfort and limiting their access to effective solutions.

One of the main barriers to treatment is the lack of awareness among both patients and health care providers. Many clinicians may only suggest Kegel exercises without exploring other available treatments, leaving patients with limited options. According to Filer, there is a significant opportunity for improvement in addressing SUI from both the patient and clinician perspectives. Screening for urinary incontinence is essential, particularly among postpartum women and older women, who are at a higher risk of experiencing the condition. Studies show that 1 in 3 postpartum women develop urinary incontinence within 3 months after childbirth, and many continue to experience symptoms years later.

To ensure patients receive proper care, Filer urged OB-GYNs and primary care providers to actively screen for urinary incontinence and educate women about available treatment options. One promising treatment discussed by Filer was Flyte, a device that utilizes mechanotherapy to provide results comparable to surgery. This at-home treatment requires only 5 minutes of use per day for 6 weeks, making it a convenient and effective solution for patients.

By integrating routine screening and increasing awareness of treatment options, health care providers can help women overcome the stigma surrounding SUI and access the care they need to improve their quality of life.

This video is part 1 of a 2-part series. Click 

Pelvital announces pivotal article highlighting efficacy of transvaginal mechanotherapy as first-line treatment for stress urinary incontinence. Pelvital. February 12, 2025. Accessed March 14, 2025. https://www.prweb.com/releases/pelvital-announces-pivotal-article-highlighting-efficacy-of-transvaginal-mechanotherapy-as-first-line-treatment-for-stress-urinary-incontinence-302374521.html.

Many women struggle with stress urinary incontinence but delay treatment because of embarrassment and lack of awareness, highlighting a need for screening and innovative treatments.

Clinical

Dr. Wanda Filer discusses how to overcome barriers to SUI treatment

Thank you for visiting the Contemporary OB/GYN® website. Take a look at some of our top stories from last week (Monday, March 10, 2025 - Friday, March 14, 2025), and click each link to read and watch anything you may have missed.

Revi System shows efficacy against urgency urinary incontinence

 John PFA Heesakkers, MD, PhD, MBA, with Maastricht Universitair Medisch Centrum, discussed the results of a study evaluating the efficacy of the Revi System, a neuromodulation-based treatment for urgency urinary incontinence.

The study, which has data from a 2-year period, included 150 participants and focused on the long-term effectiveness of the Revi System. Early in the study, a smaller cohort was used to examine the system's safety, and the results indicated that it was safe to use. While the initial aim was to assess safety, the secondary goal of evaluating efficacy showed promising results.

Heesakkers reported that after 2 years, 79% of participants experienced a reduction of more than 50% in urinary incontinence episodes, demonstrating the Revi System's effectiveness in addressing the condition. This long-term data is particularly notable as it suggests the system offers a durable solution to a common and often distressing medical issue.

Sleep health linked to type 2 diabetes risk in women with gestational diabetes

The risk of type 2 diabetes (T2D) is increased among women with gestational diabetes (GD) sleeping less and snoring occasionally or regularly, according to a recent study published in 

There were 2891 women with GD history aged a mean 45.3 years included in the analysis, 19.5% of whom reported T2D during follow-up. Of participants, 92.7% were White while 7.3% were other race or ethnicity.

A significant association was reported between snoring and T2D, with a hazard ratio (HR) of 2.17 for occasional snoring and 2.66 for regular snoring when compared to never snoring after adjusting for covariates. When further adjusting for BMI, these HRs were 1.54 and 1.61, respectively.

Study reveals low but rising cervical cancer risk after screening exit

While risks of cervical cancer and cervical cancer mortality are low among US women fulfilling the criteria to exit screening with contesting, these risks increase with age and the time since exiting, according to a recent study published in 

Similar 3-year risks were reported across the 4 models in scenario 1, ranging from 0.035% to 0.038%. While this exceeded the upper bound of the 95% confidence interval (CI) from Landy et al, the 5-year risks were within the 95% CI ranging from 0.075% to 0.083%.

In scenario 3, the 3-year risks also exceeded the 95% CI while 5-year risks fell within the 95% CI. Ranges were 0.032% to 0.048% and 0.076% to 0.092%, respectively. No link was reported between adhering to US screening guidelines and reduced CIN3 risks vs scenario 1. However, higher CIN3 risks were reported in scenario 3.

Financial rewards for smoking cessation boost neonatal birth weight

Neonatal weight may be increased through offering financial rewards for smoking cessation during pregnancy, according to a recent study published in 

There were 12 studies included in the final analysis, reporting a combined relative risk of 2.43 for smoking cessation toward the end of pregnancy. One trial was excluded from complier average causal effects (CACE) analyses because of a negative estimated compliance rate.

In the trials reporting birth weight, a mean 46.30 g increase was reported among neonates born to women in the financial rewards group vs controls. The CACE analysis highlighted an increase of 206 g among neonates of women who stopped smoking because of financial incentives. This evidence was graded as moderate because of potential imprecision in the effect estimate.

Robotic-assisted laparoscopy increases endometrial cancer survival rates

Robotic-assisted laparoscopy surgery (RALS) leads to a slight increase in survival benefit in endometrial cancer (EC) vs conventional laparoscopy surgery (CLS), according to a recent study published in the 

American Journal of Obstetrics & Gynecology.

Patients were stratified based on overweight status and age. The overall operating time was reported as the primary outcome, while secondary outcomes included short-term surgical complications, overall survival (OS), progression-free survival, and long-term surgical complications.

Improved OS was reported in the RALS group vs the CLS group, and this improvement remained when only evaluating stage 1 and stage 2 patients. Death was reported in 23.7% of patients overall, 32.7% in the CLS group, and 14.6% of the RALS group.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

Contemporary OB/GYN week in review: The Revi System, sleep health, and more

This middle-aged woman has severe dysmenorrhea and pelvic discomfort. Ultrasound images of the uterus are shown. What is your diagnosis?

Daily Dx: Dysmenorrhea and Pelvic Discomfort

These are 3D ultrasound images of a 14-week fetus. What is your diagnosis?

occipital meningocele and umbilical hernia

Beryl Benacerraf, MD

Articles

Latest Updated Articles